Summary

Bioanalytical Technologies' mission is to support the IBRI's research areas by helping to innovate the next generation of bioanalytical systems and methods. These efforts support and help enable the IBRI's development of new standards of patient care and therapeutics.

The Bioanalytical Technologies team is developing state-of-the art technology platforms and methods for bioanalytical applications in life sciences. These tools make it possible to measure the most basic elements of cell biology and solve today’s problems in biomolecular analysis with detection limits far lower than current methods. This enables far greater clarity for studying the complexity of biological systems.

Lab Team

Anna Geisinger

Anna Geisinger

Research Associate, Bioanalytical Technologies

Anna Geisinger

Anna Geisinger

Research Associate, Bioanalytical Technologies

Anna Geisinger is a research associate in the IBRI’s Bioanalytical Technologies group. Bioanalytical Technologies supports all of the IBRI’s research centers by helping to innovate the next generation of bioanalytical systems and methods. In her role, Anna is responsible for cell and bacteria culture, assay validation and protocol development, and molecular analysis.

Anna joined the IBRI in November of 2017 as a research analyst in the IBRI’s Single Cell Analytics Center (SCAC), which developed a technology platform to ultimately achieve the diagnosis of infections and diseases from a single cell. With the efforts to commercialize the platform externally, in May 2019, the SCAC transitioned to the internal Bioanalytical Technologies support group.

From 2016 to before joining the IBRI, Anna served as a microbiologist with the Indiana State Department of Health Laboratories. She was responsible for assay development and testing, clinical testing, and outbreak monitoring. From 2011 to 2016, she served as a contractor research associate at then Dow AgroSciences (now Corteva Agriscience) responsible for nucleic acid and protein isolation, molecular analysis, and high-throughput experience associated with DNA isolation and analysis.

Anna earned her B.S. in biology from Indiana University in Bloomington, Ind., with minors in chemistry and Spanish. While at IU, she also served as an undergraduate teaching assistant in the biology department.


Highlights and Publications

  • Pugia, Michael & J Newman, David & A Lott, John & D'Mello, Lucia & Clark, Larry & A Profitt, James & Cast, Todd. (2003). Detection of low-molecular-weight proteins in urine by dipsticks. Clinica chimica acta; international journal of clinical chemistry. 326. 177-83. 10.1016/S0009-8981(02)00304-2. 
  • Pugia, Michael & Takemura, Toskihiho & Kuwajima, Shiro & Suzuki, Motoyohisa & K Cast, Todd & A Profit, James & S Schulman, Lloyd & Ohta, Yoshihide & A Lott, John. (2002). Clinical utility of a rapid test for uristatin. Clinical biochemistry. 35. 105-10. 10.1016/S0009-9120(02)00288-6.
  • A. Bartsch, Richard & L. Cowey, Charles & Elshani, Sadik & Goo, Mi-Ja & Huber, Vincent & N. Ivy, Sheryl & J. Johnson, Russell & Seung Kim, Jong & Luboch, Elzbieta & A. Mcdonough, Joseph & Pugia, Michael & Son, Byungki. (2001). Synthesis of lariat ether carboxylic acids based on dibenzo-16-crown-5. Journal of Heterocyclic Chemistry - J HETEROCYCL CHEM. 38. 311-331. 10.1002/jhet.5570380201.
  • Shihabi, Zak & P Schwartz, R & Pugia, Michael. (2001). Decreasing the variability observed in urine analysis. Annals of clinical and laboratory science. 31. 99-102.